Tarsa Therapeutics, Inc.: Series A $24M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - Osteoporosis, XX - NJ

Tarsa Therapeutics (Boonton, NJ) a clinical stage small molecule company focused on osteoporosis closed a $24M Series A financing. Participants include MVM Life Science Partners, Quaker BioVentures and Novo Ventures.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Aug

2009

Zosano Pharma, Inc.: Series B $30M

Posted in I - Series B, Q - 3Q09, R - WEST, X - Device (Delivery), X - Influenza, X - Osteoporosis, XX - CA

Zosano Pharma (Fremont, CA) a clinical-stage device company focused on a transdermal microprojection delivery system for needle-free administration therapeutic peptides, small molecules and vaccines. Participants include Nomura Phase4 Ventures, New Enterprise Associates, HBM BioVentures and ProQuest Investments.

Dec

2008

Radius Health, Inc.: Series C $82.5M

Posted in I - Series C, Q - 4Q08, R - NORTH EAST, X - Endometriosis, X - Osteoporosis

Radius Health (Cambridge, MA) early-stage company focused on development of therapeutics for osteoporosis and women’s health, closed a $82.5M Series C financing. Participants include MPM Capital, The Wellcome Trust, HealthCare Ventures, Oxford Bioscience Partners, BB Biotech Ventures and Scottish Widows Investment Partnership.

to top of page...